A Phase I Study to Evaluate the Safety,Pharmacokinetics,Pharmacodynamics,and Efficacy of TJ037130 in Adult Participants With Advanced Solid Tumors
Clinical trial NCT07715747 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07715747
- Sponsor
- TJ Biopharma Co., Ltd.
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-08-21
- Primary completion
- 2028-06-30
- Enrollment
- 128
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.